On‐label and off‐label prescribing patterns of erythropoiesis‐stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes
Sign Up to like & getrecommendations! Published in 2017 at "Research in Social and Administrative Pharmacy"
DOI: 10.1016/j.sapharm.2016.07.005
Abstract: Background: A number of policy and labeling interventions aimed at reducing inappropriate prescribing of erythropoiesis‐stimulating agents (ESAs) were implemented in the U.S. between 2006 and 2010. These interventions included the addition of an FDA Black… read more here.
Keywords: label; use; period major; esa use ... See more keywords